What is Establishment Labs's market cap?

Establishment Labs (ESTA) has a market capitalization of $2.7B and trades on NASDAQ.

What is Establishment Labs's revenue and profitability?

Establishment Labs generated $229.6M in trailing twelve-month revenue with a net loss of $43.7M, representing a net margin of -19.1%. Gross margin stands at 70.1%, with free cash flow of -$41.6M. These figures are based on the Q1 2026 filing.

Who are Establishment Labs's competitors?

Establishment Labs's key competitors include Allergan, Mentor Worldwide, TELA Bio, Inc. Common Stock, and others. These companies compete in similar markets and product categories.

Who does Establishment Labs partner with?

Establishment Labs's notable partners include RTW Investments, Meghan Trainor.

Where is Establishment Labs headquartered?

Establishment Labs is headquartered in Costa Rica and employs approximately 781 people. It has been publicly traded since 2018.

Establishment Labs

ESTA

Establishment Labs is a global medical technology company specializing in advanced breast aesthetics and reconstruction solutions.

Market cap

$2.71B+123%

Revenue$229.6M+34.9%

Net income-$43.7M+50.9%

Free cash flow-$41.6M+41.9%

EPS (diluted)-$1.48+52.4%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 6, 2026

Revenue$59.9MBeat by $2.5M EPS-$0.40Miss by $0.05

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$65.8M

EPS estimate-$0.34

Financials

Q1 2026

Income statement

See full

Revenue$59.9M+44.7%

Gross profit$42.3M+52.2%

Operating income-$6.5M+61.6%

Net income-$13.4M+35.4%

EPS (diluted)-$0.45+35.7%

Balance sheet

See full

Cash & equivalents$68.1M-1.6%

Total debt$252.7M+12.0%

Total equity$14.8M-61.7%

Total assets$351.0M+5.3%

Cash flow

See full

Operating cash flow-$4.3M+79.2%

CapEx$1.9M+146%

Free cash flow-$6.2M+71.3%

Valuation & ratios

Valuation

See full

Market cap$2.71B+123%

Enterprise value$2.9B+106%

P/S11.8×+4.9×

Profitability

See full

Gross margin70.1%+3.7pp

Operating margin-12.4%-4.8pp

Net margin-19.1%-7.4pp

FCF margin-18.1%-6.6pp

Returns & leverage

See full

Return on equity-164%-17.8pp

Debt / equity17.1×+11.2×

Current ratio3×-0.4×

Segments

By geography

See full

OUS$40.3M—

Competitors

By market cap

Johnson & Johnson$640.91B+60.1%

AbbVie$453.91B+36.3%

Globus Medical$10.6B+44.5%

Establishment Labs$2.7B+121%

IAR

Integra LifeSciences$1.5B+49.2%

Artivion$1.3B-14.0%

Orthofix Medical Inc.$481.0M+7.7%

TELA Bio$29.1M-61.3%

By revenue growth

Establishment Labs+34.9%

Globus Medical+23.5%

Artivion+17.6%

AbbVie+9.5%

Johnson & Johnson+8.1%

Orthofix Medical Inc.+2.6%

IAR

Integra LifeSciences+1.6%

By net margin

Johnson & Johnson21.48%-3.5pp

Globus Medical18.92%+11.5pp

AbbVie5.79%-1.5pp

Artivion2.55%+8.0pp

IAR

Integra LifeSciences-0.44%+32.4pp

Orthofix Medical Inc.-7.27%+10.5pp

Establishment Labs-19.05%+33.3pp

Profile

Establishment Labs is a global medical technology company specializing in advanced breast aesthetics and reconstruction solutions. The company's core value proposition centers on improving patient safety and aesthetic outcomes through proprietary silicone gel-filled implants that feature lower complication rates compared to traditional legacy products.

Competitive position

Establishment Labs is a high-growth challenger in the breast implant market, positioning itself as a safer, technology-driven alternative to long-standing industry incumbents.

GeographiesUnited States, Costa Rica, Brazil, Global

Customer segmentsMedical Professionals, Healthcare Facilities

Business modelDirect-to-provider sales, Distributor-based wholesale, Manufacturing

SuppliersSilicone raw material suppliers, RFID technology components, Specialized manufacturing equipment

CustomersPlastic and reconstructive surgeons, Third-party medical device distributors, Surgical centers

CountryCosta Rica

Listed2018

Employees781.0

CEOFillipo Peter Caldini

SectorHealthcare

IndustryMedical - Devices

Websiteestablishmentlabs.com

FilingsSEC EDGAR

Ask your AI about Establishment Labs.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Establishment Labs's market cap?: Establishment Labs (ESTA) has a market capitalization of $2.7B and trades on NASDAQ.
What is Establishment Labs's revenue and profitability?: Establishment Labs generated $229.6M in trailing twelve-month revenue with a net loss of $43.7M, representing a net margin of -19.1%. Gross margin stands at 70.1%, with free cash flow of -$41.6M. These figures are based on the Q1 2026 filing.
Who are Establishment Labs's competitors?: Establishment Labs's key competitors include Allergan, Mentor Worldwide, TELA Bio, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
Who does Establishment Labs partner with?: Establishment Labs's notable partners include RTW Investments, Meghan Trainor.
Where is Establishment Labs headquartered?: Establishment Labs is headquartered in Costa Rica and employs approximately 781 people. It has been publicly traded since 2018.